A long list of healthcare stakeholders have signed a letter urging strong support for the Acute Hospital Care at Home waiver program in upcoming government funding decisions.
Writing to Congress this week, the organizations – including HIMSS (parent company of Healthcare IT News), AARP, American Telemedicine Association, Minnesota Hospital Association, Intermountain Health, Mass General Brigham, St. Luke’s Health System, UCAHealth and numerous others organized by Moving Health Home – said the evidence speaks for itself.
Patients, caregivers and providers are generally in strong support of at-home acute care, they said, and as such lawmakers should support the proposed five-year hospital-at-home waiver extension because the model has helped improve patient outcomes, lower healthcare costs and bolster older Americans’ access to medical care.
Moreover, it “will not lead to new costs” – they said in their letter on Wednesday.
They pointed to a 2022 study of patients at a New York City hospital, admitted to either hospital-at-home or inpatient care between September 2014 and August 2017, which found that one hospital-at-home program reduced costs by nearly $6,000 per patient compared with inpatient care.
Further, the Centers for Medicare and Medicaid Services has previously found that patients in hospital-at-home programs have lower mortality rates, readmissions and spending post-discharge, while resulting in positive patient and provider experiences, the 140 organizations pointed out.
These and other studies warrant the continued investment and innovation proposed in the Hospital Inpatient Services Modernization Act (S. 2237/H.R. 4313), they told the Democratic and Republican leaders.